ÂÜÀòÂÒÂ×

Brandon Lam has extensive experience in the biopharmaceutical industry. Brandon started their career in 2003 as a Development Associate III at Cell Genesys, Inc., where they developed and executed stability studies for cell-based cancer vaccines. In 2005, they joined Abgenix, Inc. as a Bioanalytical Specialist III, before moving on to MedImmune/AstraZeneca in 2006. At MedImmune/AstraZeneca, they held the position of Associate Scientist II and assumed the roles and responsibilities of the principal investigator/bioanalytical assay manager. Brandon provided bioanalytical strategies, authored method validation plans and reports, and supervised and managed analysts contributing to GLP and clinical studies. In 2017, they joined CytomX Therapeutics as a Scientist II.

Brandon Lam holds a Bachelor's degree in Genetics from the University of California, Davis.